AT1 Receptor as a Potential Target in Amphetamine-induced Neuroinflammation

Protein Pept Lett. 2022;29(5):371-374. doi: 10.2174/0929866529666220330154218.
No abstract available

MeSH terms

  • Amphetamine* / pharmacology
  • Angiotensin II
  • Angiotensin II Type 1 Receptor Blockers / pharmacology
  • Carrier Proteins
  • Humans
  • Neuroinflammatory Diseases
  • Receptor, Angiotensin, Type 1* / metabolism

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Carrier Proteins
  • Receptor, Angiotensin, Type 1
  • Angiotensin II
  • Amphetamine